| 2025-12-21 |
YASVBOM0076789 |
GLENMARK PHARMACEUTICALS LTD |
10474.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-11-23 |
YASVBOM0076738 |
GLENMARK PHARMACEUTICALS LTD |
3287.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-11-02 |
YASVBOM0076513 |
GLENMARK PHARMACEUTICALS LTD |
1546.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-10-06 |
YASVBOM0075097 |
GLENMARK PHARMACEUTICALS LTD |
3603.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-14 |
YASVBOM0074600 |
GLENMARK PHARMACEUTICALS LIMITED |
2443.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-05-21 |
YASVBOM0071738 |
GLENMARK PHARMACEUTICALS LTD |
10440.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-05-14 |
YASVBOM0071732 |
GLENMARK PHARMACEUTICALS LTD |
1995.0 kg |
300510
|
PHARMACEUTICAL COMMODTIY |
| 2025-05-14 |
YASVBOM0071734 |
GLENMARK PHARMACEUTICALS LTD |
5278.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-05-14 |
YASVBOM0071739 |
GLENMARK PHARMACEUTICALS LTD |
11077.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-05-14 |
YASVBOM0071736 |
GLENMARK PHARMACEUTICALS LTD |
10806.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-30 |
YASVBOM0071311 |
GLENMARK PHARMACEUTICALS LTD |
10467.0 kg |
|
PHARACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0070986 |
GLENMARK PHARMACEUTICALS LTD |
10180.0 kg |
300510
|
PHARMACEUTICAL COMMODITY. |
| 2025-04-17 |
YASVBOM0070988 |
GLENMARK PHARMACEUTICALS LTD |
6156.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0071030 |
GLENMARK PHARMACEUTICALS LTD |
852.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0070981 |
GLENMARK PHARMACEUTICALS LTD |
3255.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0070982 |
GLENMARK PHARMACEUTICALS LTD |
3227.0 kg |
300510
|
PHARMACEUTICAL COMMODITY. |
| 2025-04-17 |
YASVBOM0070980 |
GLENMARK PHARMACEUTICALS LTD |
10048.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0070984 |
GLENMARK PHARMACEUTICALS LTD |
9773.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0071026 |
GLENMARK PHARMACEUTICALS LTD |
14300.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0071034 |
GLENMARK PHARMACEUTICALS LTD |
7651.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-17 |
YASVBOM0071027 |
GLENMARK PHARMACEUTICALS LTD |
9070.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-02 |
YASVBOM0070280 |
GLENMARK PHARMACEUTICALS LTD |
6959.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-02 |
YASVBOM0070321 |
GLENMARK PHARMACEUTICALS LTD |
11957.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-03-27 |
YASVBOM0070271 |
GLENMARK PHARMACEUTICALS LTD |
9385.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-02-07 |
YASVBOM0068571 |
GLENMARK PHARMACEUTICALS LTD |
11286.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-02-07 |
YASVBOM0068572 |
GLENMARK PHARMACEUTICALS LTD |
12003.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-02-07 |
YASVBOM0068609 |
GLENMARK PHARMACEUTICALS LTD |
3084.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-02-07 |
YASVBOM0068608 |
MANKIND PHARMA LTD |
5288.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-01-12 |
YASVBOM0068071 |
GLENMARK PHARMACEUTICALS LTD |
5066.0 kg |
300680
|
PHARMACEUTICALS |
| 2024-11-25 |
YASVBOM0067016 |
GLENMARK PHARMACEUTICALS LTD |
392.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2023-11-22 |
MAEU232705132 |
GLENMARK PHARMACEUTICALS LTD |
382.84 kg |
726570
|
5 PALLETS 489 CARTONS PHAR MACEUTICALS AS UNDER LEVONO RGESTREL TAB 1.5MG 1 NDC CODE :72657012311 FDA PRODUCT CODE NO.: 64 G C A 29 H. T. S NO .: 3006.60.0000 ANDA NO.: 20 7044 THERAPEUTICE USE: :#AN ESTROGEN/PROGESTIN COC INDICA TED FOR USE BY WOMEN TO PREV ENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F224520035 96 DT. 26.10.2023 S/BILL NO: 4932740 DT 27-OCT-2023 NET WT .176.040 KGS 01 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK THERAPEUTICS INC., USA 3 01 ISLAND ROAD, SUITE A NEW J ERSEY MAHWAH, - 07430 USA |
| 2023-08-29 |
MAEU230005841 |
VKT PHARMA PRIVATE LIMITED |
3234.17 kg |
602200
|
14 PALLETS 2451 CARTONS PHA RMACEUTICALS AS UNDER FAMOTID INE TABLETS, USP10 MG NDC NO. 72657011220 FDA PRODUCT CODE NO.:60 S A A 22 H. T. S NO. : 3004.90.92.55 ANDA NO.: 21 5822 FAMOTIDINE TABLETS, USP2 0 MG NDC NO. 72657011388 FDA PRODUCT CODE NO.:60 S A A 22 H. T. S NO.: 3004.90.92.55 ANDA NO.: 215822 FAMOTIDINE TABLETS, USP20 MG NDC NO. 726 57011320 FDA PRODUCT CODE NO .:60 S A A 22 H. T. S NO.: 3 004.90.92.55 ANDA NO.: 215822 01 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES COMME RCIAL & CUSTOM INVOICE NO. VK T/EX/015/23-24 DT. 31.07.2023 S/BILL NO:2916489 ST:02.08.20 23 NET WT:2059.300 NOTIFY PA RTY:2 GLENMARK THERAPEUTICS I NC. USA 301, ISLAND RD, SUITE A NEW JERSEY MAHWAH USA- 0 7430 |
| 2023-06-03 |
YASVBOM0055931 |
GLENMARK PHARMACEUTICALS LTD |
194.0 kg |
642900
|
PHARMACEUTICALS AS UNDER LEVONORGESTREL TA B 1.5MG 1 NDC CODE:72657010811 FDA PRODUCT CODE NO.: 64 G C A 29 H. T. S NO.: 3006.60 .0000 ANDA NO.: 207044 THERAPEUTICE USE: :# AN ESTROGEN/PROGESTIN COC INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES |
| 2023-02-20 |
KWEO530440059441 |
GLENMARK PHARMACEUTICALS LTD |
3168.0 kg |
970600
|
ROPINIROLE TAB 0.25MG 100 1 X 40FT REEFER |
| 2023-02-20 |
KWEO530440059430 |
GLENMARK PHARMACEUTICALS LTD |
7226.0 kg |
970600
|
ROPINIROLE TAB 1MG 100 1 X 40FT REEFER |
| 2023-02-20 |
KWEO530440059371 |
GLENMARK PHARMACEUTICALS LTD |
1698.0 kg |
842111
|
IMIQUIMOD CREAM 1 X 40FT REEFER |